Influence of photodynamic therapy on immunological aspects of disease - an update

Bibliography

• DOUGHERTY TJ, GOMER CJ, HENDERSON G et al: Photodynamic therapy. J. Natl. Cancer Inst. (1998) 90:889–905.
   PubMed Web of Science ®Google Scholar
• •This review is a collaborative work by many of the top investigators involved in PDT. The state of knowledge related to mechanisms of photosensitiser action at the subcellular level, antitumour immunity and PDT as well as the clinical use of PDT is updated.
   Google Scholar
• BRESSLER NM: Photodynamic therapy of subfoveal choroidal neovascularization in age-related macular degeneration with verteporfin: one-year results of 2 randomized clinical trials-TAP report. Treatment of age-related macular degeneration with photodynamic therapy (TAP) Study Group. Arch. Ophthalmol. (1999) 117:1329–1345.
   Google Scholar
• MOSHFEGHI DM, PEYMAN GA, MOSHFEGHI AA, KHOOBEHI B, PRIMBS GB, CREAN DH: Ocular vascular thrombosis following tin ethyl etiopurpurin (SnET2) photodynamic therapy: time dependencies. Ophthalmic Surg. Lasers (1998) 29:663–668.
   PubMedGoogle Scholar
• WOODBURN KW, FAN Q, KESSEL D et al.: Phototherapy of cancer and atheromatus plaque with texaphyrins. J. Clin. Laser Med. Surg. (1996) 14:343–348.
   PubMedGoogle Scholar
• ADILL F, STATIUS RG, VAN EPS RG, LAMURAGLIA GM: Significance of dosimetry in photodynamic therapy of injured arteries: classification of biological responses. Photochem. Photobiol. (1999) 70:663–668.
   PubMed Web of Science ®Google Scholar
• JENKINS MP, BUONACCORSI GA, RAPHAEL M et al: Clinical study of adjuvant photodynamic therapy to reduce restenosis following femoral angioplasty. Br. J. Surg. (1999) 86:1258–1263.
   PubMed Web of Science ®Google Scholar
• CALZAVARA-PINTON PG, SZEIMIES R-M, ORTEL B, ZANE C: Photodynamic therapy with systemic administra-tion of photosensitisers in dermatology. J. Photochem. Photobiol Biol. (1996) 35:225–231.
   Google Scholar
• HUNT DWC, LEVY JG: Immunomodulatory aspects of photodynamic therapy. Exp. Opin. Invest. Drugs (1998) 7:57–64.
   PubMedGoogle Scholar
• GOLLNICK SO, LIU X, OWCZARCZAK B, MUSSER DA,HENDERSON BW: Altered expression of interleukin 6 and interleukin 10 as a result of photodynamic therapy in vivo. Cancer Res. (1997) 57:3904–3909.
   PubMed Web of Science ®Google Scholar
• KORBELIK M, DOUGHERTY GJ: Photodynamic therapy-mediated immune response against subcuta-neous mouse tumors. Cancer Res. (1999) 59:1941–1946.
   PubMed Web of Science ®Google Scholar
• PENG Q, BERG K, MOAN J, KONGSHAUG M, NESLAND JM:5-aminolevulinic acid-based photodynamic therapy: principles and experimental research. Photochem. Photobiol. (1997) 65:235–251.
   PubMed Web of Science ®Google Scholar
• SIMKIN GO, KING DE, CHAN AH, HUNT DWC: Inhibitionof contact hypersensitivity with different analogs of benzoporphyrin derivative. Immunopharmacology (1997) 37:221–230.
   PubMedGoogle Scholar
• KESSEL D, LUO Y: Photodynamic therapy: a mitochon-drial inducer of apoptosis. Cell Death Diff (1999) 6:28–35.
   PubMed Web of Science ®Google Scholar
• GRANVILLE DJ, CARTHY CM, HUNT DW, McMANUS BM: Apoptosis: molecular aspects of cell death and disease. Lab. Invest. (1998) 78:893–913.
   PubMed Web of Science ®Google Scholar
• ZAIDI SI, OLEINICK NL, ZAIM MT, MUKHTAR H: Apoptosis during photodynamic therapy-induced ablation of RIF-1 tumors in C311 mice: electron microscopic, histopathologic and biochemical evidence. Photochem. Photobiol. (1993) 58:771–776.
   PubMed Web of Science ®Google Scholar
• WOODBURN KW, FAN Q, MILES DR, KESSEL D, LOU Y, YOUNG SW: Localization and efficacy analysis of the phototherapeutic lutetium texaphyrin (PCI-0123) in the murine EMT6 sarcoma model. Photochem. Photobiol. (1997) 65:410–415.
   PubMed Web of Science ®Google Scholar
• LEGRAND-POELS S, SCHOONBROODT S, MATROULE JY, PIETTE J: NK-KB: an important transcription factor in photobiology. J Photochem. Photobiol. (1999) 45:1–8.
   Web of Science ®Google Scholar
• MATROULE JY, BONIZZI G, MORLIERE P et al.: Pyropheophorbide-a methyl ester-mediated photosensitization activates transcription factor NF-KB through the interleukin-1 receptor-dependent signaling pathway. J Biol Chem. (1999) 274:2988–3000.
   PubMed Web of Science ®Google Scholar
• GRANVILLE DJ, CARTHY CM, JIANG H et al: NF-KB activation by the photochemotherapeutic agent verteporfin. Blood (2000) 95:256–262.
   PubMed Web of Science ®Google Scholar
• MATROULE J-Y, HELLIN A-C, MORLIERE et al: Role of nuclear factor-KB in colon cancer cell apoptosis mediated by aminopyropheophorbide photosensiti-zation. Photochem. Photobiol. (1999) 70:540–548.
   PubMed Web of Science ®Google Scholar
• •This work provides strong evidence that NF-KB nuclear translocation in PDT-treated cells instigates productive gene transcription. Further, NF-KB activation provides a partial degree of protection against a loss in viability for PDT-treated cells.
   Google Scholar
• TAO, J, SANGHERA JS, PELECH SL, WONG G, LEVY JG: Stimulation of stress-activated protein kinase and p38 HOG1 kinase in murine keratinocytes following photodynamic therapy with benzoporphyrin deriva-tive. J. Biol. Chem. (1996) 271:27107–27115.
   PubMed Web of Science ®Google Scholar
• KLOTZ L-0, FRITSCH C, BRIVIBA K, TSACMACIDIS N, SCHLIESS F, SIES H: Activation of JNK and p38 but not ERK MAP kinases in human skin cells by 5-aminolevulinate-photodynamic therapy. Cancer Res. (1998) 58:4297–4300.
   PubMed Web of Science ®Google Scholar
• XUE L-Y, HE J, OLEINICK NL: Promotion of photody-namic therapy-induced apoptosis by stress kinases. Cell Death Diff. (1999) 6:855–864.
   PubMed Web of Science ®Google Scholar
• ASSEFA Z, VANTIEGHEM A, DECLERCQ W et al.: The activation of the c-Jun terminal kinase and p38 mitogen-activated protein kinase signaling pathways protects HeLa cells from apoptosis following photody-namic therapy with hypericin. J. Biol. Chem. (1999) 274:8788–8796.
   PubMed Web of Science ®Google Scholar
• OLEINICK N, EVANS HH: The photobiology of photody-namic therapy: cellular targets and mechanisms. RadiaL Res. (1998) 150:S146–S156.
   Google Scholar
• KESSEL D, LOU Y: Mitochondrial photodamage and PDT-induced apoptosis. J. Photochem. Photobiol (1998) 42:89–95.
   Web of Science ®Google Scholar
• KESSEL D, LUO Y, MATHIEU P, REINERS JJ: Determinants of the apoptotic response to lysosomal photodamage. Photochem. Photobiol. (2000) 71:196–200.
   PubMed Web of Science ®Google Scholar
• SUSIN SA, LORENZO HK, ZAMZAMI N et al.: Mitochon-drial release of caspase-2 and -9 during the apoptotic process. J. Exp. Med. (1999) 189:381–394.
   PubMed Web of Science ®Google Scholar
• GRANVILLE DJ, LEVY JG, HUNT DWC: Photodynamic therapy induces caspase-3 activation in HL-60 cells. Cell Death Diff (1997) 4:623–628.
   PubMed Web of Science ®Google Scholar
• GRANVILLE DJ, JIANG H, AN MT, LEVY JG, McMANUS BM, HUNT DW: Overexpression of Bc1-X(L) prevents caspase-3-mediated activation of DNA fragmentation factor (DEE) produced by treatment with the photochemotherapeutic agent BPD-MA. FEBS Lett. (1998) 422:151–154.
   PubMed Web of Science ®Google Scholar
• GRANVILLE DJ, JIANG H, AN MT, LEVY JG, McMANUS BM, HUNT DW: Bc1-2 overexpression blocks caspase activa-tion and downstream apoptotic events instigated by photodynamic therapy. Br. J. Cancer (1999) 79:95–100.
   PubMed Web of Science ®Google Scholar
• GRANVILLE DJ, CARTHY CM, JIANG H, SHORE GC, McMANUS BM, HUNT DW: Rapid cytochrome c release, activation of caspases 3, 6, 7 and 8 followed by Bap31 cleavage in HeLa cells treated with photodynamic therapy. FEBS Lett. (1998) 437:5–10.
   PubMed Web of Science ®Google Scholar
• CARTHY CM, GRANVILLE DJ, JIANG H et al: Early release of mitochondrial cytochrome c and expression of mitochondrial epitope 7A6 with a porphyrin-derived photosensitiser: Bc1-2 and Bc1-xL overexpression do not prevent early mitochondrial events but still depress caspase activity. Lab. Invest. (1999) 79:953–965.
   PubMed Web of Science ®Google Scholar
• ••This work showed that PDT with verteporfin and red lighttriggered immediate mitochondrial apoptosis-related events in HeLa cells. These rapid changes were not prevented by overexpression of the anti-apoptotic Bc1–2 or Bc1-xL proteins while these factors completely prevented features associ-ated with UVB light-induced apoptosis. Further, PDT-induced cell death was more rapid than that caused by UVB light irradiation. This work was the first to demonstrate the involvement of the initiator factor caspase-9 in PDT-induced apoptosis.
   Google Scholar
• GRANVILLE DJ, SHAW JR, LEONG S et al.: Release of cytochrome c, Box migration, Bid cleavage and activa-tion of caspases 2, 3, 6, 7, 8 and 9 during endothelial cell apoptosis. Am. J. Pathol. (1999) 55:1021–1025.
   Google Scholar
• HE J, WHITACRE CM, XUE L, BERGER NA, OLEINICK NL: Protease activation and cleavage of poly(ADP-ribose) polymerase: an integral part of apoptosis in response to photodynamic treatment. Cancer Res. 58:940–946.
   Google Scholar
• VANTIEGHEM A, ASSEFA Z, VANDENABEELE et al: Hypericin-induced photosensitization of HeLa cells leads to apoptosis or necrosis. Involvement of cytochrome c and procaspase-3 activation in the mechanism of apoptosis. FEBS Lett. (1998) 440:19–24.
   Google Scholar
• VARNES ME, CHIU S-M, XUE L-Y, OLEINICK NL: Photody-namic therapy-induced apoptosis in lymphoma cells: translocation of cytochrome c causes inhibition of respiration as well as caspase activation. Biochem. Biophys. Res. Comm. (1999) 255:673–679.
   PubMed Web of Science ®Google Scholar
• KING DE, JIANG H, SIMKIN GO, OBOCHI MO, LEVY JG, HUNT DW: Photodynamic alteration of the surface receptor expression pattern of murine splenic dendritic cells. Scand. j Immunol (1999) 49:184–192.
   PubMed Web of Science ®Google Scholar
• JIANG H, GRANVILLE DJ, MCMANUS BM, LEVY JG, HUNT DW: Selective depletion of a thymocyte subset in vitro with an immunomodulatory photosensitiser. Clin. Immunol. (1999) 91:178–187.
   PubMed Web of Science ®Google Scholar
• HUNT DW, JIANG H, GRANVILLE DJ, CHAN AH, LEONG S, LEVY JG: Consequences of the photodynamic treatment of resting and activated peripheral T lymphocytes. Immunopharmacology (1999) 41:31–44.
   PubMed Web of Science ®Google Scholar
• FOX FE, NIU Z, TOBIA A, ROOK AH: Photoactivated hypericin is an anti-proliferative agent that induces a high rate of apoptotic death of normal, transformed and malignant T lymphocytes: implications for the treatment of cutaneous lymphoproliferative and inflammatory disorders. J. Invest. Dermatol. 111:327–332.
   Google Scholar
• HRYHORENKO EA, RITTENHOUSE-DIAKUN K, HARVEY NS, MORGAN J, STEWART CC, OSEROFF AR: Characteri-zation of endogenous protoporphyrin IX induced by delta-aminolevulinic acid in resting and activated peripheral blood lymphocytes by four-color flow cytometry. Photochem. Photobiol. (1998) 67:565–572.
   PubMed Web of Science ®Google Scholar
• HRYHORENKO EA, OSEROFF AR, MORGAN J, RITTENHOUSE-DIAKUN K: Deletion of alloantigen-activated cells by aminolevulinic acid-based photody-namic therapy. Photochem. Photobiol (1999) 69:560–565.
   PubMed Web of Science ®Google Scholar
• BANCHEREAU J, STEINMAN RM: Dendritic cells and the control of immunity. Nature (1998) 392:245–252.
   PubMed Web of Science ®Google Scholar
• HRYHORENKO EA, OSEROFF AR, MORGAN J, RITTENHOUSE-DIAKUN K: Antigen specific and nonspecific modulation of the immune response by aminolevulinic acid based photodynamic therapy. Immunopharmacology (1998) 40:231–240.
   PubMedGoogle Scholar
• GIESELER R, HEISE D, SORURI A, SCHWARTZ P, PETERS JH: In-vitro differentiation of mature dendritic cells from human blood monocytes. Dev. Immunol. (1998) 6:25–39.
   PubMedGoogle Scholar
• THOMAS R, MACDONALD KP, PETTIT AR, CAVANAGH LL,PADMANABHA J, ZEHNTNER S: Dendritic cells and the pathogenesis of rheumatoid arthritis. J. Leukoc. (1999) 66:286–292.
   PubMed Web of Science ®Google Scholar
• PETTIT AR, THOMAS R: Dendritic cells: the driving force behind autoimmunity in rheumatoid arthritis? Immunol. Cell Biol. (1999) 77:420–427.
   Web of Science ®Google Scholar
• KOCH F, STANZL U, JENNEWEIN P et al: High level IL-12 production by murine dendritic cells: Up-regulation via MHC Class II and CD40 molecules and downregula-tion by IL-4 and IL-10. J. Exp. Med. (1996) 184:741–746.
   PubMed Web of Science ®Google Scholar
• REDDAN JC, ANDERSON CY, HUT X et al.: Immunosup-pressive effects of silicon phthalocyanine photody-namic therapy. Photochem. Photobiol (1999) 70:72–77.
   PubMedGoogle Scholar
• SIMKIN GO, TAO J-S, LEVY JG, HUNT DWC: IL-10 contrib-utes to the inhibition of contact hypersensitivity in mice treated with photodynamic therapy. J. Immunol (2000) 164:2457–2462.
   PubMed Web of Science ®Google Scholar
• RIEMANN H, SCHWARZ A, GRABBE S et al.: Neutraliza-tion of IL-12 in vivo prevents induction of contact hypersensitivity and induces hapten-specific tolerance. J. Immunol. (1996) 156:1799–1803.
   PubMed Web of Science ®Google Scholar
• CASPI RR: IL-12 in autoimmunity. Clin. Immunol.Immunopathol (1998) 88:4–13.
   PubMedGoogle Scholar
• RATKAY LG, CHOWDHARY RK, IAMAROON A et al.: Amelioration of antigen-induced arthritis in rabbits by induction of apoptosis of inflammatory cells with local application of transdermal photodynamic therapy. Arthritis Rheum. (1998) 41:525–534.
   PubMed Web of Science ®Google Scholar
• HENDRAK-HENION JA, KNISELY TL, CINCOTTA L, CINCOTTA E, CINCOTTA AH: Role of the immune system in mediating the antitumor effect of benzophe-nothiazine photodynamic therapy. Photochem. Photobiol (1999) 69:575–581.
   PubMed Web of Science ®Google Scholar
• KORBELIK M, CECIC I: Enhancement of tumour response to photodynamic therapy by adjuvant mycobacterium cell-wall treatment. J. Photochem. Photobiol (1998) 44:151–158.
   Web of Science ®Google Scholar
• KORBELIK M, CECIC I: Contribution of myeloid andlymphoid host cells to the curative outcome of mouse sarcoma treatment by photodynamic therapy. Cancer Lett. (1999) 137:91–98.
   PubMed Web of Science ®Google Scholar
• COUTIER S, BEZDETNAYA L, MARCHAL S et al.: Foscan (mTHPC) photosensitized macrophage activation: enhancement of phagocytosis, nitric oxide release and tumour necrosis factor-alpha-mediated cytolytic activity. Br. J. Cancer (1999) 81:37–42.
   PubMed Web of Science ®Google Scholar
• ALBERT ML, SAUTER B, BHARDWAJ N: Dendritic cells acquire antigen from apoptotic cells and induce class I-restricted CTLs. Nature (1998) 392:86–89.
   PubMed Web of Science ®Google Scholar
• ALBERT ML, PEARCE SFA, FRANCISCO LM et al: Immature dendritic cells phagocytic cells via cc,f35 and CD36 and cross-present antigens to cytotoxic T lymphocytes. J. Exp. Med. (1998) 188:1359–1368.
   PubMed Web of Science ®Google Scholar
• SCHULER G, STEINMAN RM: Dendritic cells as adjuvants for immune-mediated resistance to tumors. J. Exp. Med. (1997) 186:1183–1187.
   PubMed Web of Science ®Google Scholar
• YOUNG JW, INABA K: Dendritic cells as adjuvants for Class I major histocompatibility complex-restricted antitumour immunity. J. Exp. Med. (1998) 183:7–11.
   Web of Science ®Google Scholar
• LEE BY, GOLLNICK SO, OWCZARCZAK B, HENDERSON: Detection of tumor antigens in the lymph node following Photofrin® photodynamic therapy (PDT). Photochem. Photobiol. (1999) 69:10S.
   Google Scholar
• BOS JD, DE RIE MA: The pathogenesis of psoriasis: immunological facts and speculations. Immunol Today (1999) 20:40–46.
   PubMedGoogle Scholar
• OZAWA M, FERENCZI K, KIKUCHI T et al.: 312-nanometer ultraviolet B light (narrow-band UVB) induces apoptosis of T cells within psoriatic lesions. J. Exp. Med. (1999) 189:711–718.
   PubMed Web of Science ®Google Scholar
• VALLAT VP, GILLEAUDEAU P, BATTAT L et al.: PUVA bath therapy strongly suppresses immunological and epidermal activation in psoriasis: a possible cellular basis for remittive therapy. J. Exp. Med. (1994) 180:283–296.
   PubMed Web of Science ®Google Scholar
• BISSONNETTE R, McLEAN DI, REID G, KELSALL J, LUI H:Photodynamic therapy of psoriasis and psoriatic arthritis with BPD verteporfin. 7th Biennial Congress of the International Photodynamic Association. Nantes France, July 7–9, (1998). Abstract RC87.
   Google Scholar
• BOEHNCKE W, ELSHORST-SCHMIDT T, KAUFMANN R: Systemic photodynamic therapy is a safe and effective treatment of psoriasis. Arch. Dermatol. (2000) 136:271–272.
   PubMed Web of Science ®Google Scholar